Key Issues in End Point Selection for Heart Failure Trials: Composite End Points
- 1 October 2005
- journal article
- perspective
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 11 (8) , 567-575
- https://doi.org/10.1016/j.cardfail.2005.08.350
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Validity of composite end points in clinical trialsBMJ, 2005
- Cardiac Replacement with a Total Artificial Heart as a Bridge to TransplantationNew England Journal of Medicine, 2004
- The use of hospital admission data as a measure of outcome in clinical studies of heart failurePublished by Oxford University Press (OUP) ,2003
- Combined endpoints: can we use them?Statistics in Medicine, 2002
- Human Immunodeficiency Virus Type 1 RNA Level and CD4 Count as Prognostic Markers and Surrogate End Points: A Meta-AnalysisAIDS Research and Human Retroviruses, 2000
- Use of a Global Test for Multiple Outcomes in Stroke Trials With Application to the National Institute of Neurological Disorders and Stroke t-PA Stroke TrialStroke, 1996
- Considerations in choice of a clinical endpoint for AIDS clinical trialsStatistics in Medicine, 1994
- Reduction in burden of illness: A new efficacy measure for prevention trialsStatistics in Medicine, 1994
- The use of subjective rankings in clinical trials with an application to cardiovascular diseaseStatistics in Medicine, 1992
- A sharper Bonferroni procedure for multiple tests of significanceBiometrika, 1988